September 17- EOD

Not a lot of stock specific news but some interesting larger biotech developments. The market held up better than I thought given yesterday’s close and biotechs seemed like slight underperformers but not to the same degree as yesterday.   That being said I think the CLVS news seemed to bring in some buyers, so they ended […]

September 16- EOD

It was a strong day in the market but a weak day in biotech. That being said I think there was a definite pattern in that the large caps and biopharmas seemed to outperform (although they were still weaker than the market) than the mid- and small- caps. In my mind, I read that as […]

September 16- EOD

It was a strong day in the market but a weak day in biotech. That being said I think there was a definite pattern in that the large caps and biopharmas seemed to outperform (although they were still weaker than the market) than the mid- and small- caps. In my mind, I read that as […]

September 16- EOD

It was a strong day in the market but a weak day in biotech. That being said I think there was a definite pattern in that the large caps and biopharmas seemed to outperform (although they were still weaker than the market) than the mid- and small- caps. In my mind, I read that as […]

September 13- EOD

Generally a mixed day in biotech land today with some interesting stock specific moves but nothing really dramatic in terms of news. Looks like a quiet end to the week with stocks essentially performing in line with the broader market. 1. ECYT was up nicely today on the back of a Seeking Alpha article by […]

September 12- EOD

Another relatively weak day in biotech land but this is not to say that the market in general was particularly strong. It is not surprising that both the market and biotechs seems to be taking a breather and would also not be surprising to see it last more than a few days. That being said, […]

September 12- EOD

Another relatively weak day in biotech land but this is not to say that the market in general was particularly strong. It is not surprising that both the market and biotechs seems to be taking a breather and would also not be surprising to see it last more than a few days. That being said, […]

September 12- EOD

Another relatively weak day in biotech land but this is not to say that the market in general was particularly strong. It is not surprising that both the market and biotechs seems to be taking a breather and would also not be surprising to see it last more than a few days. That being said, […]

September 11- Morning

This is both an early and short report for today as I am on sick child duty for the day. Luckily it was not a particularly newsy morning and if there is something particularly compelling I will write a short note this evening. 1. I did want to follow up on the SGMO abstracts that […]

September 10- EOD

Decent day in the market but biotechs did not seem to participate to the same extent. Of course, I do not have much time to follow the market on Tuesday but today seemed more like a consolidation day for biotechs than a follow through. There was a decent amount of red on my screen with […]

September 9- EOD

Some interesting news today and generally a positive market environment, although some of the recent high fliers seemed to take most of the day off. That is not completely surprising to see a pause in the moves. 1. BIOD was the stock of the weekend (and morning) given that they released what was originally argued […]

September 6- EOD

The week ended with some interesting action and volatility over Syria news. The markets appear jumpy but note that the sell off was over the words of Putin. I think a limited American led strike is basically accepted and priced in but the key will be the response. If Syria (and Russia/Iran) accept it and […]

September 6- EOD

The week ended with some interesting action and volatility over Syria news. The markets appear jumpy but note that the sell off was over the words of Putin. I think a limited American led strike is basically accepted and priced in but the key will be the response. If Syria (and Russia/Iran) accept it and […]

September 6- EOD

The week ended with some interesting action and volatility over Syria news. The markets appear jumpy but note that the sell off was over the words of Putin. I think a limited American led strike is basically accepted and priced in but the key will be the response. If Syria (and Russia/Iran) accept it and […]

September 5- EOD

As I noted before, Tuesday and Thursday will likely be shorter updates given my schedule but there is some important news that came out for some companies that I want to touch on. The market still seems to be looking for a direction but in general it seems like sentiment is improving. Certainly something we […]

September 4- EOD

There was some nice action in biotech land today despite not being particularly busy in terms of news. There was some interesting stock specific action and the sector was a mixed bag. Stocks without specific news tended to underperform but not universally so. The next couple of months will be interesting as volume will likely […]

September 3- EOD

I am going to try and cover what was a fairly busy day in biotech land but Tuesday and Thursday will necessarily be shorter than usual. The semester has started again and I spend most of Tuesday and Thursday teaching, which does not provide as much time to write notes but I will still provide […]

August 30- EOD

Well, perhaps this is the last time I will write this for awhile but a slow day in the market and news front. I guess it makes sense as the last day of trading before the long Labor Day weekend but still not a lot to talk about at all. The only notable action was […]

August 29- EOD

We got a trickle of some interesting biotech news but still nothing dramatic. I suspect that the pace will increase in September as the summer ends and the fall healthcare conference season begins. 1. PCYC announced the acceptance of the NDA for previously treated mantle cell lymphoma (MCL) and previously treated chronic lymphocytic leukemia (CLL)/small […]

August 28- EOD

Again, it is a quite day in the biotech realm as the market essentially treads water waiting for the strike on Syria before deciding on its next direction. The market was strong early on and then seemed to fade alter in the day and for the most part it seems that biotechs either followed the […]